Adtalem Global Education (NYSE:CVSA) Given Outperform Rating at Barrington Research

Adtalem Global Education (NYSE:CVSA)‘s stock had its “outperform” rating restated by stock analysts at Barrington Research in a research report issued on Monday,Benzinga reports. They currently have a $170.00 target price on the stock. Barrington Research’s price objective indicates a potential upside of 33.93% from the company’s previous close.

Several other analysts have also recently commented on the stock. Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, Truist Financial lifted their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Adtalem Global Education has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Price Performance

Shares of CVSA stock traded up $0.29 on Monday, hitting $126.94. The stock had a trading volume of 63,404 shares, compared to its average volume of 372,361. The firm has a 50 day moving average of $119.37. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $156.26. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market capitalization of $4.32 billion, a price-to-earnings ratio of 19.77, a P/E/G ratio of 1.05 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The business had revenue of $487.03 million during the quarter. During the same period in the prior year, the firm posted $1.92 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities analysts forecast that Adtalem Global Education will post 8.04 EPS for the current year.

Insider Activity

In other Adtalem Global Education news, Director Michael W. Malafronte acquired 8,890 shares of the stock in a transaction on Wednesday, March 11th. The stock was purchased at an average price of $100.94 per share, for a total transaction of $897,356.60. Following the purchase, the director directly owned 25,395 shares in the company, valued at $2,563,371.30. This trade represents a 53.86% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Robert J. Phelan sold 10,000 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $126.21, for a total transaction of $1,262,100.00. Following the completion of the sale, the chief financial officer owned 55,806 shares in the company, valued at approximately $7,043,275.26. This trade represents a 15.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders bought 36,036 shares of company stock worth $3,635,302 and sold 37,489 shares worth $4,815,956. Company insiders own 2.50% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.